Biomarker driven treatment of head and neck squamous cell cancer
Eze N, Lo YC, Burtness B. Biomarker driven treatment of head and neck squamous cell cancer. Cancers Of The Head & Neck 2017, 2: 6. PMID: 31093353, PMCID: PMC6460531, DOI: 10.1186/s41199-017-0025-1.Peer-Reviewed Original ResearchNeck squamous cell cancerSquamous cell cancerCell cancerPredictive biomarkersNeck cancerClinical practicePredictive biomarker developmentImmune checkpoint inhibitionPlasma EBV DNATreatment-related toxicityNovel predictive biomarkerNeck cancer therapyTreatment of headCancer therapyImmune checkpoint biomarkersQuality of lifeLong-term functionEBV DNAIndividualized cancer therapyTargeted agentsCheckpoint inhibitionTreatment modalitiesSurrogate biomarkerP16 overexpressionNasopharyngeal carcinoma